US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 8.600
  • +0.170+2.02%
Close Apr 26 16:00 ET
125.58MMarket Cap-10886P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Coya Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

6.00M

0.00%
EPS(YoY)

0.15

+146.72%
Analyst Rating

Buy

Mar 31, 2024

Coya Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q46.000M / 7.500M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q46.000M / 7.500M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--

Coya Therapeutics Earnings Reports

  • Coya Therapeutics | 10-K: Annual report

    Mar 19 08:31 ET

  • Coya Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 09:07 ET

  • Coya Therapeutics | 10-Q: Quarterly report

    Aug 8, 2023 07:09 ET

  • Coya Therapeutics | 10-Q: Quarterly report

    May 10, 2023 07:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg